# Phase 1 Study of 3D229 in Healthy Subjects

> **NCT04941313** · PHASE1 · COMPLETED · sponsor: **3D Medicines** · enrollment: 24 (actual)

## Conditions studied

- Healthy Subject

## Interventions

- **DRUG:** 3D229
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04941313
- **Lead sponsor:** 3D Medicines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-27
- **Primary completion:** 2021-11-15
- **Final completion:** 2022-02-21
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04941313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04941313, "Phase 1 Study of 3D229 in Healthy Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04941313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*